<DOC>
	<DOCNO>NCT00002441</DOCNO>
	<brief_summary>The purpose study see HIV vaccine , AIDSVAX B/B , protect adult risk become infect HIV . Patients become infected despite immunization study see receiving vaccine become infect help keep HIV level ( viral load ) low .</brief_summary>
	<brief_title>Effectiveness HIV Vaccine HIV-Negative Adults North America Who Are Risk HIV Infection</brief_title>
	<detailed_description>Volunteers receive 7 blind , intramuscular vaccination ( Months 0 , 1 , 6 , 12 , 18 , 24 , 30 ) contain either AIDSVAX B/B vaccine placebo ( aluminum adjuvant ) . Volunteers randomize 2 1 vaccine-to-placebo ratio . HIV-uninfected person follow total 16 visit begin screen continue Month 36 . Patients become HIV infect study follow every 4 month least 24 month .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Exclusion Criteria You eligible study : Use injection drug . Have history serious disease condition , include lymphoma . Have ever receive HIV vaccine . Have take postexposure treatment prevent HIV infection within 4 week prior study entry . Are plan take HIV vaccine study . Are pregnant . Have take certain medication receive certain therapy , include chemotherapy radiation . Have receive certain vaccine within 24 week prior study entry . You may eligible study : Are HIVnegative . Are 18 60 year old . Are available 3 year followup . Agree use effective method birth control study 90 day . Are one follow : A woman currently sexual relationship HIVpositive man . A woman one male partner least one sexually transmitted disease ( STD ) within past 12 month . A man sex men anal intercourse within past 12 month . ( You eligible relationship one HIVnegative man least 12 month . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2000</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS Vaccines</keyword>
	<keyword>Sexually Transmitted Diseases</keyword>
	<keyword>Risk Factors</keyword>
	<keyword>HIV Seronegativity</keyword>
	<keyword>Antigens , Viral</keyword>
	<keyword>Alum Compounds</keyword>
</DOC>